Literature DB >> 17473916

The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.

Davide Quarta1, Christopher G Naylor, Ian P Stolerman.   

Abstract

RATIONALE: There is evidence that serotonin(2C) (5-HT(2C)) receptors can modulate some behavioural effects of nicotine, but the generality of this action is not known.
OBJECTIVE: To analyse the influence of the 5-HT(2C) agonist Ro-60-0175 on responses to nicotine in the five-choice serial reaction time task (5-CSRTT) and on its discriminative stimulus effect; these procedures constitute models for attention-enhancing and subjective effects of nicotine, respectively.
MATERIALS AND METHODS: In the 5-CSRTT, rats were trained to obtain food reinforcers by detecting light stimuli and then challenged with Ro-60-0175 (0.3-0.8 mg/kg) and nicotine (0.2 mg/kg). For drug discrimination studies, rats were trained to discriminate nicotine (0.2 mg/kg) from saline in a two-lever procedure using a tandem schedule of food reinforcement.
RESULTS: In the 5-CSRTT, nicotine positively influenced most response indices, confirming previous results. Ro-60-0175 increased response latencies and omission errors and reduced anticipatory responding but had little effect on response accuracy; importantly, it counteracted the effects of nicotine on response speed and omission errors. Pentobarbitone (10-14 mg/kg) also slowed performance of the 5-CSRTT but did not weaken the nicotine-induced enhancement of performance. In the drug discrimination procedure, Ro-60-0175 was not generalised with nicotine but shifted the nicotine dose-response curve to the right in a dose-related manner.
CONCLUSIONS: The data suggest that selective occupancy of 5-HT(2C) receptors can attenuate some effects of nicotine in the 5-CSRTT and weaken the nicotine discriminative stimulus; these effects cannot be explained by a sedative action of Ro-60-0175.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473916     DOI: 10.1007/s00213-007-0802-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  63 in total

1.  Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior.

Authors:  A J Grottick; P J Fletcher; G A Higgins
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

Review 2.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

Review 3.  Stimulant drugs and vigilance performance: a review.

Authors:  H S Koelega
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  Drugs of abuse: behavioural principles, methods and terms.

Authors:  I Stolerman
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

5.  Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.

Authors:  M Gasior; M Shoaib; S Yasar; M Jaszyna; S R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

6.  Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

Authors:  Philippe De Deurwaerdère; Sylvia Navailles; Kelly A Berg; William P Clarke; Umberto Spampinato
Journal:  J Neurosci       Date:  2004-03-31       Impact factor: 6.167

7.  Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.

Authors:  Vincenzo Di Matteo; Massimo Pierucci; Ennio Esposito
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

8.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  Brain Res Mol Brain Res       Date:  1994-04

9.  Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands.

Authors:  B Hahn; M Shoaib; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2002-03-23       Impact factor: 4.530

10.  The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.

Authors:  Guy A Higgins; Michel Enderlin; Marie Haman; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2003-08-07       Impact factor: 4.530

View more
  13 in total

1.  Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.

Authors:  Laura Agnoli; Mirjana Carli
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

2.  Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist.

Authors:  Mark G LeSage; David Shelley; Marco Pravetoni; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2012-04-04       Impact factor: 3.533

Review 3.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

4.  Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.

Authors:  Paul J Fletcher; Maria Tampakeras; Judy Sinyard; Guy A Higgins
Journal:  Psychopharmacology (Berl)       Date:  2007-08-03       Impact factor: 4.530

5.  Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists.

Authors:  Guy A Higgins; Leo B Silenieks; Everett B Altherr; Cam MacMillan; Paul J Fletcher; Wayne E Pratt
Journal:  Psychopharmacology (Berl)       Date:  2016-05-30       Impact factor: 4.530

6.  The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control.

Authors:  Guy A Higgins; Leo B Silenieks; Anne Rossmann; Zoe Rizos; Kevin Noble; Ashlie D Soko; Paul J Fletcher
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

Review 7.  Pharmacological enhancement of memory and executive functioning in laboratory animals.

Authors:  Stan B Floresco; James D Jentsch
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

8.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

9.  Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.

Authors:  G A Higgins; L B Silenieks; W Lau; I A M de Lannoy; D K H Lee; J Izhakova; K Coen; A D Le; P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2012-11-25       Impact factor: 4.530

10.  Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice.

Authors:  Paul J Fletcher; Ashlie D Soko; Guy A Higgins
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.